Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/06/426
Active ingredient: Fenretinide
Indication: Treatment of primary malignant bone tumours
Sponsor: Cancer Research UK
Angel Building, 407 St John Street, London EC1V4AD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2007 Orphan designation EMEA/OD/082/06 (2007)318 of 26/01/2007
23/02/2011 Removal of orphan designation from Community Register
01/03/2011 Change of name and/or address of sponsor EMEA/OD/082/06